Clinical and experimental studies of phenytoin-induced hyperkinesias

Bellman, M. H., Haas, L. Toxic reaction to phenytoin. Br. Med. J.2, 256?257 (1974).

Chadwick, D., Reynolds, E. H., Marsden, C. D. Anticonvulsant-induced dyskinesias: comparison with dyskinesias induced by neuroleptics. J. Neurol. Neurosurg. Psychiatry39, 1210?1218 (1976).

Chalhub, E. G., Devivo, D. C., Volpe, J. J. Phenytoin-induced dystonia and choreoathetosis in two retarded epileptic children. Neurology26, 494?498 (1976).

DeVeaugh-Geiss, J. Aggravation of tardive dyskinesia by phenytoin. New Eng. J. Med.298, 457?458 (1978).

Ernst, A. M. Relation between the action of dopamine and apomorphine and their O-methylated derivatives upon the CNS. Psychopharmaco-logia7, 391?399 (1965).

Gerber, N., Lynn, R., Oates, J. Acute intoxication with 5,5-diphenyl-hydantoin associated with impairment of biotransformation. Ann. Intern. Med.77, 765?771 (1972).

Hitri, A., Weiner, W. J., Borison, R. L., Diamond, B., Klawans, H. L. Dopamine binding following prolonged haloperidol pretreatment. Ann. Neurol.3, 134?140 (1978).

Iivanainen, M., Viukari, Seppalaine, M., Helle, E. P. Electroence-phalography and phenytoin toxicity in mentally retarded epileptic patients. J. Neurol. Neurosurg. Psychiat.41, 272?277 (1978).

Klawans, H. L., Weiner, W. J. The pharmacology of choreatic movement disorders. In: Progress in Neurobiology (Kerkut, G. A., Phillis, J. W., eds.), pp. 1?32. Oxford: Pergamon Press. 1975.

Klawans, H. L. The pharmacology of tardive dyskinesias. Am. J. Psychiatry130, 82?86 (1973).

Klawans, H. L., Paulson, G. W., Ringel, S. P., Barbeau, A. Use of L-dopa in the detection of presymptomatic Huntington's chorea. N. Eng. J. Med.286, 1332?1334 (1972).

Kookier, J. C., Sumi, S. M. Movement disorder as a manifestation of diphenylhydantoin intoxication. Neurology24, 68?71 (1974).

Lennox, W. G., Lennox, M. A. Epilepsy and related disorders. Boston: Little, Brown and Co. 1960.

Logan, W. H., Freeman, H. M. Pseudodegenerative disease due to diphenylhydantoin intoxication. Arch. Neurol.21, 631?637 (1969).

Luhdorf, K., Lund, M. Phenytoin-induced hyperkinesia. Epilepsia18, 409?415 (1977).

McLellan, D. L., Swash, M. Choreoathetosis and encephalopathy induced by phenytoin. Br. Med. J.2, 204?205 (1974).

Mendez, J. L., Cotzias, G. C., Mena, I., Papavasiliou, P. S. Diphenylhydantoin: Blocking of levodopa effect. Arch. Neurol.32, 44?46 (1975).

Merritt, H. H., Putnam, T. J. Sodium diphenylhydantoin in the treatment of convulsive disorders. JAMA11, 1068?1073 (1938).

Nausieda, P. A., Koller, W. C., Klawans, H. L., Weiner, W. J. Phenytoin and choreatic movements. New Eng. J. Med.298, 1093?1094 (1978).

Opida, C. L., Korthals, J. K., Somasundaram, M. Bilateral ballismus in phenytoin intoxication. Ann. Neurol.3, 186 (1978).

Paine, R. S. The evolution of infantile postural reflexes in the presence of chronic brain syndromes. Develop. Med. Child. Neurol.6, 345?361 (1964).

Peters, H. A., Eichman, P. L., Price, J. M. Abnormal copper and tryptophan metabolism and chelation therapy in anticonvulsant drug intolerance. Dis. Nerv. Syst.27, 97?107 (1966).

Rasmussen, S., Kristensen, M. Choreoathetosis during phenytoin treatment. Acta Medica. Scand.201, 239?241 (1977).

Reynolds, E. H. Chronic antiepileptic toxicity; a review. Epilepsia16, 319?352 (1975).

Rosenblum, E., Rodochok, L., Hanson, P. Movement disorder as a manifestation of diphenylhydantoin toxicity. Pediatrics64, 364?366 (1974).

Shuttleworth, E., Wise, G., Paulson, G. Choreathetosis and diphenylhydantoin intoxication. JAMA230, 1170?1171 (1974).